Brain volume loss linked to Alzheimer’s treatment may be caused by amyloid plaque removal

A loss of brain volume associated with new immunotherapies for Alzheimer’s disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led by UCL researchers.

What to expect from hospitals and health insurers at this year’s JPM Healthcare Conference

Nonprofit hospitals often get overshadowed at the J.P. Morgan Healthcare Conference, the health care industry’s swankiest investor meeting whose agenda is dominated by drugmakers and

January 7, 2024

GSK to spend $800M to build two vaccine factories in the US

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Brain volume loss linked to Alzheimer’s treatment may be caused by amyloid plaque removal

UK Aid awards funding to Oxford Vaccine Group for research into prevention of five epidemic threats

What to expect from hospitals and health insurers at this year’s JPM Healthcare Conference

GSK to spend $800M to build two vaccine factories in the US

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe